Literature DB >> 19855199

Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease.

Shahrzad Mavandadi1, Sarra Nazem, Thomas R Ten Have, Andrew D Siderowf, John E Duda, Matthew B Stern, Daniel Weintraub.   

Abstract

OBJECTIVES: A range of psychiatric symptoms and cognitive deficits occur in Parkinson disease (PD), and symptom overlap and comorbidity complicate the classification of nonmotor symptoms. The objective of this study was to use analytic-based approaches to classify psychiatric and cognitive symptoms in PD.
DESIGN: Cross-sectional evaluation of a convenience sample of patients in specialty care.
SETTING: Two outpatient movement disorders centers at the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center. PARTICIPANTS: One hundred seventy-seven patients with mild-moderate idiopathic PD and without significant global cognitive impairment. MEASUREMENTS: Subjects were assessed with an extensive psychiatric, neuropsychological, and neurological battery. Latent class analysis (LCA) was used to statistically delineate group-level symptom profiles across measures of psychiatric and cognitive functioning. Predictors of class membership were also examined.
RESULTS: Results from the LCA indicated that a four-class solution best fit the data. The 32.3% of the sample had good psychiatric and normal cognitive functioning, 17.5% had significant psychiatric comorbidity but normal cognition, 26.0% had few psychiatric symptoms but had poorer cognitive functioning across a range of cognitive domains, and 24.3% had both significant psychiatric comorbidity and poorer cognitive functioning. Age, disease severity, and medication use predicted class membership.
CONCLUSIONS: LCA delineates four classes of patients in mild-moderate PD, three of which experience significant nonmotor impairments and comprise over two thirds of patients. Neuropsychiatric symptoms and cognitive deficits follow distinct patterns in PD, and further study is needed to determine whether these classes are generalizable, stable, predict function, quality of life, and long-term outcomes and are amenable to treatment at a class level.

Entities:  

Mesh:

Year:  2009        PMID: 19855199      PMCID: PMC2848973          DOI: 10.1097/JGP.0b013e3181b215ec

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  32 in total

1.  Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview study of patients living at home.

Authors:  M Caap-Ahlgren; O Dehlin
Journal:  Arch Gerontol Geriatr       Date:  2001-02       Impact factor: 3.250

2.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 3.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

4.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.

Authors:  D Aarsland; J P Larsen; J L Cummins; K Laake
Journal:  Arch Neurol       Date:  1999-05

5.  Depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; P L Bolduc; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1990-01       Impact factor: 2.254

6.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

7.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

8.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

9.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

10.  A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia.

Authors:  A McKinlay; R C Grace; J C Dalrymple-Alford; T Anderson; J Fink; D Roger
Journal:  Parkinsonism Relat Disord       Date:  2007-07-12       Impact factor: 4.891

View more
  13 in total

Review 1.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Authors:  Irene Litvan; Jennifer G Goldman; Alexander I Tröster; Ben A Schmand; Daniel Weintraub; Ronald C Petersen; Brit Mollenhauer; Charles H Adler; Karen Marder; Caroline H Williams-Gray; Dag Aarsland; Jaime Kulisevsky; Maria C Rodriguez-Oroz; David J Burn; Roger A Barker; Murat Emre
Journal:  Mov Disord       Date:  2012-01-24       Impact factor: 10.338

Review 2.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 3.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

4.  Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis.

Authors:  Laura Brennan; Kathryn M Devlin; Sharon X Xie; Dawn Mechanic-Hamilton; Baochan Tran; Howard H Hurtig; Alice Chen-Plotkin; Lama M Chahine; James F Morley; John E Duda; David R Roalf; Nabila Dahodwala; Jacqueline Rick; John Q Trojanowski; Paul J Moberg; Daniel Weintraub
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

Review 5.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

6.  Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.

Authors:  Angela H Lee; Daniel Weintraub
Journal:  Mov Disord       Date:  2012-06-01       Impact factor: 10.338

Review 7.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

8.  Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.

Authors:  Kathleen M Hayden; Maragatha Kuchibhatla; Heather R Romero; Brenda L Plassman; James R Burke; Jeffrey N Browndyke; Kathleen A Welsh-Bohmer
Journal:  Am J Geriatr Psychiatry       Date:  2013-09-27       Impact factor: 4.105

9.  A latent class analysis of psychological disturbance in Parkinson's disease.

Authors:  Laura B Zahodne; Michael Marsiske; Dawn Bowers
Journal:  Int J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 3.485

10.  Education, and the balance between dynamic and stationary functional connectivity jointly support executive functions in relapsing-remitting multiple sclerosis.

Authors:  Sue-Jin Lin; Irene Vavasour; Brenda Kosaka; David K B Li; Anthony Traboulsee; Alex MacKay; Martin J McKeown
Journal:  Hum Brain Mapp       Date:  2018-09-21       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.